Two related cases of super-refractory status epilepticus due to 4-aminopyridine intoxication and an overview of the literature
Corresponding Author
Eveline Van Looy
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Correspondence: Eveline Van Looy General Hospital Sint Jan, Department of Neurology Ruddersvoorde 10, 8000 Brugge, BelgiumSearch for more papers by this authorAnnelies Van Dycke
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Search for more papers by this authorLudo Vanopdenbosch
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Search for more papers by this authorCorresponding Author
Eveline Van Looy
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Correspondence: Eveline Van Looy General Hospital Sint Jan, Department of Neurology Ruddersvoorde 10, 8000 Brugge, BelgiumSearch for more papers by this authorAnnelies Van Dycke
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Search for more papers by this authorLudo Vanopdenbosch
General Hospital Sint Jan, Department of Neurology, Ruddersvoorde 10, 8000 Brugge, Belgium
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| epd212414-sup-9001.pdfPDF document, 350.4 KB | Slides |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Spyker D.A., Lynch C., Shabanowitz J., Sinn J.A. Poisoning with 4-aminopyridine: report of three cases. Clin Toxicol, 16 4 1980 487–497
- 2Sedehizadeh S., Keogh M., Maddison P. The use of aminopyridines in neurological disorders. Clin Neuropharmacol, 35 4 2012 191–200
- 3Cornblath D.R., Bienen E.J., Blight A.R. The safety profile of dalfampridine extended release in multiple sclerosis clinical trials. Clin Ther, 34 5 2012 1056–1069
- 4Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res, 11 1 1992 9–16
- 5King A.M., Menke N.B., Katz K.D., Pizon A.F. 4-aminopyridine toxicity: a case report and review of the literature. J Med Toxicol, 8 3 2012 314–321
- 6Ball A.P., Hopkinson R.B., Farrell I.D., Hutchinson J.G., Paul R., Watson R.D. et al., Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak. Q J Med, 48 191 1979 473–491
- 7Schwam E. Severe accidental overdose of 4-aminopyridine due to a compounding pharmacy error. J Emerg Med, 41 1 2011 51–54
- 8Ballesta Méndez M., van Pesch V., Capron A., Hantson P. Prolonged toxic encephalopathy following accidental 4-aminopyridine overdose. Case Rep Neurol Med, 2014 2014 237064
- 9Dorandeu F., Carpentier T., Baubichon D., Four E., Bernabé D., Burckhart M.F. et al., Efficacy of the ketamine–atropine combination in the delayed treatment of soman-induced status epilepticus. Brain Research, 1051 1–2 2005 164–175
- 10De Cauwer H., De Wolf P., Couvreur F., Mortelmans L. An unusual case of 4-aminopyridine toxicity in a multiple sclerosis patient: epileptic disorder or toxic encephalopathy?. Acta Neurol Belg, 109 1 2009 40–41
- 11Stork C.M., Hoffman R.S. Characterization of 4-aminopyridine in overdose. J Toxicol Clin Toxicol, 32 5 1994 583–587
- 12Smeets J.W., Kunst M.W. Ernstige intoxicatie met 4-aminopyridine bij een bodybuilder [Severe poisoning by 4-aminopyridine in a body builder]. Ned Tijdschr Geneeskd, 139 51 1995 2667–2669
- 13Burton J.M., Bell C.M., Walker S.E., O'Connor P.W. 4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis. Neurology, 71 22 2008 1833–1834
- 14Fil L.J., Sud P., Sattler S. A massive overdose of dalfampridine. West J Emerg Med, 16 7 2015 1177–1179
Citing Literature
